Theorem, Decision Driver form strategic alliance

By Zachary Brennan

- Last updated on GMT

Related tags: Medicine, Economics

Theorem, Decision Driver form strategic alliance
Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics (DDA) to integrate health economics and outcomes research, predictive modeling and definitive analysis to maximize return on investment for pharmaceutical and medical device research programs.

Decision Driver Analytics was founded in 2006 by Elizabeth Brooks, Ph.D., to provide accessible health economics analysis and strategies to drive product decisions for manufacturers and developers.

Lee Spurgin, SVP and General Manager of Theorem’s Medical Device and Diagnostic Development, told, “I’m pulling together a group of individuals to be a one-stop for device companies with clinical trials.”

He added that Ms. Brooks “allows us to look at protocol, design methodologies and determine how to save clients money. The device community has been hit over the past 24 months in terms of failures, especially for our key clients.”

Ms. Brooks and her team are “focused on reimbursement trends and economic outcomes on certain products,” Spurgin added. “We met with a large client in the Bay Area two weeks ago and they want to reduce oversight time.”

It’s a mechanism of the design of the trial and the design of the device. As we’ve evolved, we’re seeing where [a device] works in a portion of the population but not for the long-term​,” he said. “The data show some of these devices might not be as effective as once thought. But Decision Driver has seen very different models, questioning the endpoints​” of some trials.

King of Prussia-based Theorem’s move comes nearly a month since forming its strategic alliance with BioTelemetry, which includes the global cardiac core laboratory known as Cardiocore.

Knowing the right answers to key questions at critical decision points in the development process can make the difference between having the latest blockbuster or an expensive failure​,” John Potthoff, president and CEO of Theorem Clinical Research​, said. “We believe this alliance helps drive projects for clients in ways that will achieve both regulatory and marketing success​.”

Related news

Related products

show more

Local Lab Data Management

Local Lab Data Management

Q2 Solutions | 01-Jul-2020 | Technical / White Paper

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us


View more